The induction and maintenance of T cell anergy

While the "true" role of T cell anergy in promoting peripheral tolerance continues to be debated, it is clear that studying the various models of anergy have led to important insight in terms of understanding the pathways and molecules responsible for T cell activation and inhibition. This...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 120(2006), 3 vom: 15. Sept., Seite 239-46
1. Verfasser: Powell, Jonathan D (VerfasserIn)
Format: Aufsatz
Sprache:English
Veröffentlicht: 2006
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Review
LEADER 01000naa a22002652 4500
001 NLM161692915
003 DE-627
005 20231223092711.0
007 tu
008 231223s2006 xx ||||| 00| ||eng c
028 5 2 |a pubmed24n0539.xml 
035 |a (DE-627)NLM161692915 
035 |a (NLM)16581297 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Powell, Jonathan D  |e verfasserin  |4 aut 
245 1 4 |a The induction and maintenance of T cell anergy 
264 1 |c 2006 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 26.09.2006 
500 |a Date Revised 14.08.2006 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a While the "true" role of T cell anergy in promoting peripheral tolerance continues to be debated, it is clear that studying the various models of anergy have led to important insight in terms of understanding the pathways and molecules responsible for T cell activation and inhibition. This review will examine our current understanding of CD4+ T cell anergy. In particular, it will focus on the signaling pathways responsible for both the induction and maintenance of anergy. Furthermore, it will examine how specifically targeting these pathways can be exploited clinically in terms of promoting tolerance in transplantation and autoimmunity and inhibiting tumor-induced tolerance in the case of tumor-immunotherapy 
650 4 |a Journal Article 
650 4 |a Review 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 120(2006), 3 vom: 15. Sept., Seite 239-46  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:120  |g year:2006  |g number:3  |g day:15  |g month:09  |g pages:239-46 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 120  |j 2006  |e 3  |b 15  |c 09  |h 239-46